Merck & Co Inc
Veridion Score
Composite trend over time
Why is MRK moving today?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
MRK insider activity
Merck & Co Inc
24 insiders bought in the last 90 days
Net buying: $320K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | 2026-05-29 | Mayo Stephen | Insider | buy | $118.72 | 1,853 | 14,825 | $220K | SEC Form 4 |
| 2026-06-02 | 2026-05-29 | Seidman Christine E | Insider | buy | $118.72 | 1,853 | 21,228 | $220K | SEC Form 4 |
| 2026-06-02 | 2026-05-29 | Karsanbhai Surendralal Lanca | Insider | buy | $118.72 | 1,853 | 5,392 | $220K | SEC Form 4 |
| 2026-06-02 | 2026-05-29 | Coe Mary Ellen | Insider | buy | $118.72 | 1,853 | 31,766 | $220K | SEC Form 4 |
| 2026-06-02 | 2026-05-29 | Rothman Paul | Insider | buy | $118.72 | 1,853 | 34,945 | $220K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 89 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moMRK contract awards, year to date.
Public federal awards linked to this ticker.
VACCINES FOR CHILDREN
WINREVAIR 45MG/VIAL INJ,LYPHL
PHARMACEUTICAL ORDER FOR THE PUGET SOUND VA MEDICAL CENTER.
PATIENT MEDICATION OF BELZUTIFAN 40MG - ORDER PLACED FOR A PATIENT AT THE HUNTINGTON...
PHARMACY ORDER FOR VETERAN(S).
MRK lobbying filings, year to date.
Registered lobbying filings matched to Merck & Co Inc.